quinazolines has been researched along with Alveolar Soft Part Sarcoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustine, B; Chawla, SP; Chen, AP; Do, K; Doroshow, JH; George, S; Ivy, SP; Juwara, L; Keohan, ML; Kuhlmann, L; Kummar, S; Movva, S; Nguyen, J; O'Sullivan Coyne, G; Patel, SR; Razak, A; Steinberg, SM; Takebe, N | 1 |
| Maleddu, A; Wilky, BA | 1 |
| Chen, AP; Cohen, JW; Derdak, J; Dombi, E; Dompierre, J; Glod, J; Goodwin, A; Kummar, S; O'Sullivan Coyne, G; Onukwubiri, U; Steinberg, SM; Widemann, BC | 1 |
| Alcindor, T; Awan, A | 1 |
| Benson, C; Bhadri, V; Bliss, JM; Campbell-Hewson, Q; Cubedo, R; Dangoor, A; Fox, L; Hennig, I; Jarman, K; Joubert, W; Judson, I; Kernaghan, S; Kilburn, L; Leahy, M; López Pousa, A; Martinez Trufero, J; McNeil, C; Morden, JP; Seddon, B; Snowdon, C; Tattersall, M; Toms, C | 1 |
| Pasquali, S; Stacchiotti, S | 1 |
| Allen, D; Choyke, P; Doroshow, JH; Helman, L; Hose, CD; Ivy, SP; Kinders, RJ; Kummar, S; Lawrence, S; Monks, A; Polley, EC; Simon, R; Steinberg, SM; Turkbey, IB | 1 |
| Ballman, K; Sleijfer, S; Verweij, J | 1 |
3 trial(s) available for quinazolines and Alveolar Soft Part Sarcoma
| Article | Year |
|---|---|
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS).
Topics: Adolescent; Antineoplastic Agents; Child; Female; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Prognosis; Quinazolines; Sarcoma, Alveolar Soft Part; Survival Rate | 2019 |
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Topics: Adult; Aged; Antineoplastic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinazolines; Sarcoma, Alveolar Soft Part; Soft Tissue Neoplasms; Young Adult | 2019 |
Cediranib for metastatic alveolar soft part sarcoma.
Topics: Adult; Anorexia; Antineoplastic Agents; Diarrhea; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Hypertension; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Prospective Studies; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Alveolar Soft Part; Treatment Outcome; Young Adult | 2013 |
5 other study(ies) available for quinazolines and Alveolar Soft Part Sarcoma
| Article | Year |
|---|---|
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.
Topics: Humans; Indoles; Protein Kinase Inhibitors; Quinazolines; Sarcoma, Alveolar Soft Part; Sunitinib | 2023 |
Much Ado about ASPS: The Rapidly Changing Treatment Paradigms of 2022.
Topics: Antineoplastic Agents; Humans; Quinazolines; Sarcoma, Alveolar Soft Part; Sunitinib | 2023 |
Secondary polycythemia in a sarcoma patient: a commentary about cediranib.
Topics: Antineoplastic Agents; Humans; Lung Neoplasms; Male; Middle Aged; Polycythemia; Protein Kinase Inhibitors; Quinazolines; Sarcoma, Alveolar Soft Part | 2019 |
Cediranib for alveolar soft part sarcoma: a randomised study in relation to clinical practice.
Topics: Double-Blind Method; Humans; Quinazolines; Sarcoma, Alveolar Soft Part | 2019 |
The future of drug development? Seeking evidence of activity of novel drugs in small groups of patients.
Topics: Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Quinazolines; Sarcoma, Alveolar Soft Part | 2013 |